The company's shares fell 9.8% in after-market trading.

The country legalized recreational cannabis in October 2018, but profits remain elusive for most marijuana companies. Canadian weed producers have been hit by fewer-than-expected new stores, low prices and oversupply.

Last month, Aurora Cannabis announced plans to book up to C$1 billion ($749.96 million) in impairment charges and issued a bleak outlook, as the company struggles with high costs.

"Like our peers, we have faced industry challenges, but we remain committed to driving long-term value for our shareholders", Tilray's Chief Executive Officer Brendan Kennedy said.

Tilray recorded non-cash charges of $112.1 million on impairments related largely to a revenue sharing deal with shoemaker Authentic Brands Group.

In February, the company said it had cut 10% of its 1,443 workforce as part of a global restructuring to reduce costs and achieve profitability.

General and administrative expenses, however, more than doubled in the latest reported quarter.

Net loss widened to $219.1 million, or $2.14 per share, in the fourth quarter ended Dec. 31, from $31.0 million, or 33 cents per share, a year earlier.

Revenue more than tripled to $46.9 million.

($1 = 1.3334 Canadian dollars)

(Reporting by Arundhati Sarkar in Bengaluru; Editing by Shounak Dasgupta and Krishna Chandra Eluri)